PinkDx Funding: $40M Raised, Series A (2024)

PinkDx funding overview

PinkDx is a Biotech company based in Daly City, California. PinkDx has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2024. The round record for PinkDx runs through 2024; nothing later has been disclosed. Investors on record include Catalio Capital Management, LP, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic. 5 distinct backers are named across the disclosed rounds.

PinkDx at a glance

Total raised: $40M
Latest round: Series A
Latest round date: April 2024
Industry: Biotech
Headquarters: Daly City, California
Notable investors: Catalio Capital Management, LP, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic

Frequently asked about PinkDx funding

How much has PinkDx raised?: PinkDx has raised $40M in total disclosed funding across the rounds on record.
Who has invested in PinkDx?: Catalio Capital Management, LP, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic are named among the investors backing PinkDx.
What was the latest PinkDx funding round?: The most recent disclosed round is a Series A, announced in April 2024.
Where is PinkDx based?: PinkDx is based in Daly City, California.
What sector does PinkDx operate in?: PinkDx is tracked under Biotech from Daly City, California, with $40M in disclosed funding.
When did PinkDx last raise?: The last disclosed PinkDx round closed in April 2024 at Series A.

Round data for PinkDx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Daly City and backer lists below.

PinkDx Funding: $40M Raised, Series A (2024)

PinkDx funding overview

PinkDx at a glance

Frequently asked about PinkDx funding

PinkDx founders (1)

Companies related to PinkDx (19)

Browse related funding lists (4)